Long COVID Diagnostic Reactivity Assesment Test
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Electrodiagnostic Bioelectrical Assessment.
- Who it may be relevant to
- Registry conditions: Long COVID, Post-Acute Sequelae of SARS-CoV-2 Infection. Basic parameters: 18 years — 75 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Uzbekistan
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Development of a Personalized Alternative Non-invasive Rapid Diagnostic Test for SARS-CoV-2 in Patients With Long COVID
Overview
This study is a diagnostic clinical investigation designed to evaluate bioelectrical response patterns assessed by electro-acupuncture-based medicament testing. The method is used to identify individual bioelectrical reactivity associated with the presence and persistence of pathological factors and to assess patient-specific responses to tested medicinal substances. The study involves a single-session, non-invasive diagnostic procedure without administration of pharmacological treatment. The primary objective is the methodological evaluation of the diagnostic approach and the characterization of the detected bioelectrical response patterns in the studied population.
Detailed description
This study is a diagnostic clinical investigation designed to evaluate bioelectrical response patterns assessed by electro-acupuncture-based medicament testing.
The method is used to identify individual bioelectrical reactivity associated with the presence and persistence of pathological factors and to assess patient-specific responses to tested medicinal substances.
The study involves a single-session, non-invasive diagnostic procedure without pharmacological treatment. The primary objective is the methodological evaluation of the diagnostic approach and the characterization of the detected bioelectrical response patterns in the studied population.
Interventions
- Diagnostic test Electrodiagnostic Bioelectrical Assessment
A non-invasive diagnostic procedure performed during a single session to assess bioelectrical response patterns associated with viral antigen persistence. Measurements are obtained using standardized bioelectrical assessment techniques without administration of any therapeutic agents or interventions.
Primary outcome measures
- Number of Participants With Bioelectrical Response Patterns Consistent With Viral Persistence [Time frame: At enrollment (single diagnostic session)]
Secondary outcome measures (1)
- Distribution of Bioelectrical Reactivity Patterns During Medicament Testing [Time frame: Baseline(Day 1)]
Eligibility criteria
Inclusion criteria
- Age 18 years or older
- History of confirmed SARS-CoV-2 infection
- Persistent symptoms consistent with Long COVID lasting ≥12 weeks after acute infection
- Ability to provide informed consent
- Willingness to undergo non-invasive bioelectrical diagnostic assessment
Exclusion criteria
- Acute infectious disease at the time of enrollment
- Severe uncontrolled medical or psychiatric conditions that may interfere with diagnostic assessment
- Implanted electronic medical devices (e.g., pacemaker)
- Pregnancy or breastfeeding
- Inability to comply with study procedures
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Diagnostic
Study locations
Uzbekistan · 1 center
- Research Institute of Virology — Tashkent
Identifiers
NCT: NCT07343856 · 9/36-2216